Fate Therapeutics (FATE) Long-Term Investments (2019 - 2025)
Fate Therapeutics (FATE) reported Long-Term Investments of $1.47 million for Q4 2025, down 94.7% from $27.66 million a year earlier and down 85.7% from the prior quarter.
Powered by 
Analysis
Fate Therapeutics (FATE) Long-Term Investments (2019 - 2025) Analysis & Trends
Dating back to Q4 2019, Fate Therapeutics' Long-Term Investments record includes 22 quarters.
- Long-Term Investments has a four-year compound annual growth rate of -65.2% (FY2021 to FY2025).
- By year, Long-Term Investments came in at $27.66 million in FY2024, $980,000 in FY2023 (-80.2%), $4.94 million in FY2022 (-95.1%) and $100.66 million in FY2021.
- The Q4 2025 figure ranks as the lowest quarterly Long-Term Investments since Q4 2023.
- Year over year, Long-Term Investments has now declined in each of the last three quarters, with growth averaging 126.2% over the last six quarters.
- The high point for year-over-year Long-Term Investments in five years was Q3 2021 (growth of 843.7%); the low point was Q4 2022 (a decline of 95.1%).
- Per Business Quant data, the three quarters before Q4 2025 came in at $10.31 million (Q3 2025), $26.1 million (Q2 2025) and $32.29 million (Q1 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 4.01 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | - |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 387.00 Mn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 1.60 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | 63.00 Mn |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 268.00 Mn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | - |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | - |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 1.45 Bn |
| 10 | Fate Therapeutics | 215.18 Mn | 76.08 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 1.47 Mn |
| Sep 30, 2025 | 10.31 Mn |
| Jun 30, 2025 | 26.10 Mn |
| Mar 31, 2025 | 32.29 Mn |
| Dec 31, 2024 | 27.66 Mn |
| Sep 30, 2024 | 33.61 Mn |
| Jun 30, 2024 | 47.16 Mn |
| Mar 31, 2024 | 7.60 Mn |
| Dec 31, 2023 | 980,000.00 |
| Jun 30, 2023 | 7.29 Mn |
| Mar 31, 2023 | 3.91 Mn |
| Dec 31, 2022 | 4.94 Mn |
| Sep 30, 2022 | 13.94 Mn |
| Jun 30, 2022 | 11.93 Mn |
| Mar 31, 2022 | 67.94 Mn |
| Dec 31, 2021 | 100.66 Mn |
| Sep 30, 2021 | 124.88 Mn |
| Jun 30, 2021 | 149.50 Mn |
| Mar 31, 2021 | 98.28 Mn |
| Sep 30, 2020 | 13.23 Mn |
API Access
Fate Therapeutics Long-Term Investments API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=long-term-investments&ticker=FATE&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "long-term-investments", "ticker": "FATE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=long-term-investments&ticker=FATE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();